David A. Nielsen

8.3k total citations · 1 hit paper
118 papers, 6.4k citations indexed

About

David A. Nielsen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David A. Nielsen has authored 118 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cellular and Molecular Neuroscience, 45 papers in Molecular Biology and 27 papers in Pharmacology. Recurrent topics in David A. Nielsen's work include Neurotransmitter Receptor Influence on Behavior (47 papers), Cannabis and Cannabinoid Research (26 papers) and Substance Abuse Treatment and Outcomes (16 papers). David A. Nielsen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (47 papers), Cannabis and Cannabinoid Research (26 papers) and Substance Abuse Treatment and Outcomes (16 papers). David A. Nielsen collaborates with scholars based in United States, China and Sweden. David A. Nielsen's co-authors include Mary Jeanne Kreek, K. Steven LaForge, Eduardo R. Butelman, David J. Shapiro, D F Steiner, David Goldman, Michael Welsh, Ann Ho, Thomas R. Kosten and Vadim Yuferov and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

David A. Nielsen

115 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

2005 753 citations Mary Jeanne Kreek, David A. Nielsen et al. profile →

Peers

Countries citing papers authored by David A. Nielsen

Since Specialization

Citations

This map shows the geographic impact of David A. Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Nielsen more than expected).

Fields of papers citing papers by David A. Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Nielsen. The network helps show where David A. Nielsen may publish in the future.

Co-authorship network of co-authors of David A. Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Nielsen. A scholar is included among the top collaborators of David A. Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Nielsen. David A. Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Val/Met BDNF as a genetic risk for a false sense of security in post-discharge suicide risk 2024 ·Journal of Affective Disorders ·Katrina A. Rufino, (unknown), Michelle A. Patriquin, Thomas R. Kosten, David A. Nielsen, Ramiro Salas	1
2	Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas 2024 ·Nicotine & Tobacco Research ·Anna V. Wilkinson, Baojiang Chen, Alan C. Swann, David P. Graham, David A. Nielsen, Thomas R. Kosten, Alexandra Loukas, Dale S. Mantey, (unknown), Melissa B. Harrell	0
3	Promoter region variant C‐824T in the TH gene modulates the subjective effects of cocaine 2023 ·American Journal on Addictions ·(unknown), (unknown), David A. Nielsen, Richard De La Garza	1
4	miR-124-3p target genes identify globus pallidus role in suicide ideation recovery in borderline personality disorder 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), John M. Oldham, Michelle A. Patriquin, David A. Nielsen, Thomas R. Kosten, Ramiro Salas	1
5	A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in Suicidality 2022 ·SHILAP Revista de lepidopterología ·(unknown), Nguyễn Tiến Đạt, Savannah N. Gosnell, (unknown), Michelle A. Patriquin, Sanjay J. Mathew, Alan C. Swann, David A. Nielsen, Thomas R. Kosten, Ramiro Salas	4
6	Pharmacogenetics of Addiction Therapy 2022 ·Methods in molecular biology ·David P. Graham, Mark J. Harding, David A. Nielsen	3
7	Psychosis and synthetic cannabinoids 2018 ·Psychiatry Research ·Huiqiong Deng, Christopher D. Verrico, Thomas R. Kosten, David A. Nielsen	49
8	Apolipoprotein E DNA methylation and posttraumatic stress disorder are associated with plasma ApoE level: A preliminary study 2018 ·Behavioural Brain Research ·David A. Nielsen, Catherine J. Spellicy, Mark J. Harding, David P. Graham	10
9	Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant 2017 ·American Journal on Addictions ·Kaylah N. Curtis, Humsini Viswanath, Kenia M. Velasquez, David L. Molfese, Mark J. Harding, (unknown), Philip R. Baldwin, Elisa Ambrosi, Alok Madan, Michelle A. Patriquin, B. Christopher Frueh, J. Christopher Fowler, Thomas R. Kosten, David A. Nielsen, Ramiro Salas	27
10	Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and α1A-adrenoceptor gene variation 2013 ·European Neuropsychopharmacology ·Daryl Shorter, David A. Nielsen, (unknown), Mark J. Harding, Sara Hamon, Thomas R. Kosten	22
11	Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls 2012 ·Drug and Alcohol Dependence ·David A. Nielsen, Ann Ho, Ajay Bahl, (unknown), Scott Kellogg, Lisa Borg, Mary Jeanne Kreek	50
12	Common and specific liability to addiction: Approaches to association studies of opioid addiction 2012 ·Drug and Alcohol Dependence ·David A. Nielsen, Mary Jeanne Kreek	28
13	Litter Gender Composition and Sex Affect Maternal Behavior and DNA Methylation Levels of the Oprm1 Gene in Rat Offspring 2011 ·Frontiers in Psychiatry ·Yanli Hao, (unknown), David A. Nielsen, Therese A. Kosten	48
14	Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs 2010 ·Pharmacogenetics and Genomics ·Vadim Yuferov, David A. Nielsen, Orna Levran, Matthew Randesi, Sara Hamon, Ann Ho, Susan Morgello, Mary Jeanne Kreek	36
15	Genetic susceptibility to heroin addiction: a candidate gene association study 2008 ·Genes Brain & Behavior ·Orna Levran, Douglas Londoño, (unknown), David A. Nielsen, Einat Peles, John Rotrosen, Paul Casadonte, Shirley Linzy, Matthew Randesi, Jürg Ott, Miriam Adelson, Mary Jeanne Kreek	169
16	A transitional care service for elderly chronic disease patients at risk of readmission 2004 ·Australian Health Review ·Caroline Brand, (unknown), Adrian J. Lowe, David A. Nielsen, Carol Roberts, (unknown), Donald Campbell	40
17	A Tryptophan Hydroxylase Gene Marker for Suicidality and Alcoholism 1998 ·Archives of General Psychiatry ·David A. Nielsen, Matti Virkkunen, Jaakko Lappalainen, (unknown), Gerald L. Brown, Jeffrey C. Long, David Goldman, Markku Linnoila	239
18	Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers 1997 ·European Archives of Psychiatry and Clinical Neuroscience ·Erik G. Jönsson, David Goldman, Gillian Spurlock, Petter Gustavsson, David A. Nielsen, Markku Linnoila, Michael J. Owen, Göran C. Sedvall	99
19	2 Naturally Occurring Amino Acid Substitutions in the Human 5-HT1A Receptor: Glycine 22 to Serine 22 and Isoleucine 28 to Valine 28 1995 ·Biochemical and Biophysical Research Communications ·(unknown), David A. Nielsen, M. Linnoila, David Goldman	43
20	Formation of biologically active peptides 1980 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·Donald F. Steiner, Christoph Patzelt, Shu Jin Chan, Paul Quinn, Howard S. Tager, David A. Nielsen, Åke Lernmark, B E Noyes, K Agarwal, Kenneth H. Gabbay, Arthur H. Rubenstein	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact